5-132294825-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003059.3(SLC22A4):āc.209G>Cā(p.Arg70Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000011 in 1,458,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R70L) has been classified as Uncertain significance.
Frequency
Consequence
NM_003059.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC22A4 | NM_003059.3 | c.209G>C | p.Arg70Pro | missense_variant | 1/10 | ENST00000200652.4 | |
SLC22A4 | XM_047417594.1 | c.209G>C | p.Arg70Pro | missense_variant | 1/8 | ||
SLC22A4 | XM_011543589.3 | c.209G>C | p.Arg70Pro | missense_variant | 1/8 | ||
SLC22A4 | XM_006714675.5 | c.-216G>C | 5_prime_UTR_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC22A4 | ENST00000200652.4 | c.209G>C | p.Arg70Pro | missense_variant | 1/10 | 1 | NM_003059.3 | P1 | |
P4HA2 | ENST00000471826.1 | n.138+353C>G | intron_variant, non_coding_transcript_variant | 1 | |||||
P4HA2 | ENST00000431054.5 | c.78+353C>G | intron_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000828 AC: 2AN: 241596Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132340
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1458862Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 725668
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.209G>C (p.R70P) alteration is located in exon 1 (coding exon 1) of the SLC22A4 gene. This alteration results from a G to C substitution at nucleotide position 209, causing the arginine (R) at amino acid position 70 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 18, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SLC22A4-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with proline at codon 70 of the SLC22A4 protein (p.Arg70Pro). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and proline. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at